References
- American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.
- Baer, H. A. (1993). How critical can clinical anthropology be? Medical Anthropology, 15(3), 299–317. https://doi.org/10.1080/01459740.1993.9966096
- Bourdieu, P. (1998). Acts of resistance: Against the new myths of our time (R. Nice, Trans.). Polity Press.
- Bourgois, P. (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24(2), 165–195. https://doi.org/10.1023/a:1005574918294
- Chasnoff, I. J., Burns, W. J., Schnoll, S. H., & Burns, K. A. (1985). Cocaine use in pregnancy. The New England Journal of Medicine, 313(11), 666–669. https://doi.org/10.1056/NEJM198509123131105
- Chasnoff, I. J., Landress, H. J., & Barrett, M. E. (1990). The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. The New England Journal of Medicine, 322(17), 1202–1206. https://doi.org/10.1056/NEJM199004263221706
- Ecker, J., Abuhamad, A., Hill, W., Bailit, J., Bateman, B. T., Berghella, V., Blake-Lamb, T., Guille, C., Landau, R., Minkoff, H., Prabhu, M., Rosenthal, E., Terplan, M., Wright, T. E., & Yonkers, K. A. (2019). Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: A report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. American Journal of Obstetrics and Gynecology, 221(1), B5–28. https://doi.org/10.1016/j.ajog.2019.03.022
- Guttmacher Institute. (2018). Substance use during pregnancy. https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy
- Hansen, H., & Skinner, M. E. (2012). From white bullets to black markets and greened medicine: The neuroeconomics and neuroracial politics of opioid pharmaceuticals. Annals of Anthropological Practice, 36(1), 167–182. https://doi.org/10.1111/j.2153-9588.2012.01098.x
- Hansen, H. B., Siegel, C. E., Case, B. G., Bertollo, D. N., DiRocco, D., & Galanter, M. (2013). Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. The Journal of Behavioral Health Services & Research, 40(3), 367–377. https://doi.org/10.1007/s11414-013-9341-3
- Kern-Goldberger, A. R., Huang, Y., Polin, M., Siddiq, Z., Wright, J. D., D’Alton, M. E., & Friedman, A. M. (2019). Opioid use disorder during antepartum and postpartum hospitalizations. American Journal of Perinatology. https://doi.org/10.1055/s-0039-1694725
- Knight, K. R. (2015). Addicted.pregnant.poor. Duke University Press.
- Knight, K. R., Duncan, L. G., Szilvasi, M., Premkumar, A., Matache, M., & Jackson, A. (2019). Reproductive (in)justice – Two patients with avoidable poor reproductive outcomes. New England Journal of Medicine, 381(7), 593–596. https://doi.org/10.1056/NEJMp1907437
- Krans, E. E., & Patrick, S. W. (2016). Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstetrics and Gynecology, 128(1), 4–10. https://doi.org/10.1097/AOG.0000000000001446
- Kuehn, B. M. (2005). Methadone treatment marks 40 years. JAMA, 294(8), 887–889. https://doi.org/10.1001/jama.294.8.887
- Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science (New York, N.Y.), 278(5335), 45–47. https://doi.org/10.1126/science.278.5335.45
- Mayer, K. U. (2009). New directions in life course research. Annual Review of Sociology, 35(1), 413–433. https://doi.org/10.1146/annurev.soc.34.040507.134619
- McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695. https://doi.org/10.1001/jama.284.13.1689
- Meinhofer, A., & Anglero-Diaz, Y. (2019). Trends in foster care entry among children removed from their homes because of parental drug use, 2000 to 2017. JAMA Pediatrics, 173(9), 881. https://doi.org/10.1001/jamapediatrics.2019.1738
- Netherland, J., & Hansen, H. B. (2017). White opioids: Pharmaceutical race and the war on drugs that wasn't. BioSocieties, 12(2), 217–238. https://doi.org/10.1057/biosoc.2015.46
- Patrick, S. W., Davis, M. M., Lehman, C. U., & Cooper, W. O. (2015a). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012. Journal of Perinatology, 35(8), 650–655. https://doi.org/10.1038/jp.2015.36
- Patrick, S. W., Dudley, J., Martin, P. R., Harrell, F. E., Warren, M. D., Hartmann, K. E., Ely, E. W., Grijalva, C. G., & Cooper, W. O. (2015b). Prescription opioid epidemic and infant outcomes. Pediatrics, 135(5), 842–850. https://doi.org/10.1542/peds.2014-3299
- Patrick, S. W., & Schiff, D. M. (2017). A public health response to opioid use in pregnancy. Pediatrics, 139(3), e20164070. https://doi.org/10.1542/peds.2016-4070
- Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. Journal of the American Medical Association, 307(18), 1934–1940.
- Preis, H., Garry, D. J., Herrera, K., Garretto, D. J., & Lobel, M. (2020). Improving assessment, treatment, and understanding of pregnant women with opiod use disorder: The important of life context. Women’s Reproductive Health, 7, 153–163
- Premkumar, A., Kerns, J., & Huchko, M. J. (2020). “A resume for the baby”: Biosocial precarity and care of substance-using, pregnant women in San Francisco. Culture, Medicine and Psychiatry, 44(1), 35–55. https://doi.org/10.1007/s11013-019-09634-9
- Reddy, U. M., Davis, J. M., Ren, Z., & Greene, M. F. (2017). Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: Executive uummary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstetrics & Gynecology, 130(1), 10–28.
- Roberts, D. E. (2002). Shattered bonds: The color of child welfare. Basic Books.
- Rosenbaum, M., & Murphy, S. (1998). Pregnant women on drugs: Combating stereotypes and stigma (1st ed.). Rutgers University Press.
- Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., & Land, T. (2018). Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstetrics and Gynecology, 132(2), 466–474. https://doi.org/10.1097/AOG.0000000000002734
- Substance Abuse and Mental Health Services Administration (SAMHSA). (2016). Results from the 2015 National Survey on Drug Use and Health: Detailed tables. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf
- Wen, T., Batista, N., Wright, J. D., D’Alton, M. E., Attenello, F. J., Mack, W. J., & Friedman, A. M. (2019). Postpartum readmissions among women with opioid use disorder. American Journal of Obstetrics & Gynecology: MFM, 1(1), 89–98. https://doi.org/10.1016/j.ajogmf.2019.02.004